Johnson & Johnson Requests Emergency Authorisation For COVID Vaccine

WASHINGTON, United States (AFP) — Pharmaceuticals giant Johnson & Johnson on Thursday submitted an application for emergency authorisation of its COVID-19 vaccine with US health authorities, the company said in a statement.

J&J subsidiary Janssen Biotech “has submitted an application to the US Food and Drug Administration (FDA) requesting Emergency Use Authorisation (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate,” the statement read.

The process could take several weeks, but at the end of it the J&J vaccine would be the third authorised in the United States, after those of Pfizer-BioNTech and Moderna.

About adminrfm 3063 Articles
We, at Real fm are dedicated to change the recreation activities in the island Grenada. Our vision is to become widely known and respected as one of the best places to relax and have fun anywhere.